salbutamol and ipratropium bromide

North America

Canada (3)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
COMBIVENT RESPIMAT (20MCG+100MCG)/ACT sol
Rx
inh
R03AL02
IPRATROPIUM BROMIDE AND SALBUTAMOL SULPHATE INHALATION SOLUT sol
Rx
inh
R03AL02
TEVA-COMBO STERINEBS (2.5MG+0.5MG)/2.5ML sol
Rx
inh
R03AL02
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
COMBIVENT RESPIMAT (20MCG+100MCG)/ACT sol
02419106
IPRATROPIUM BROMIDE AND SALBUTAMOL SULPHATE INHALATION SOLUT sol
02483394
TEVA-COMBO STERINEBS (2.5MG+0.5MG)/2.5ML sol
02272695
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

United States (13)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE EQ 0.083% BASE;0.0 sol
N
inh
R03AL02
ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE EQ 0.083% BASE;0.0 sol
N
inh
R03AL02
ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE EQ 0.083% BASE;0.0 sol
Y
Rx
inh
R03AL02
ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE EQ 0.083% BASE;0.0 sol
N
inh
R03AL02
ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE EQ 0.083% BASE;0.0 sol
Y
Rx
inh
R03AL02
ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE EQ 0.083% BASE;0.0 sol
Y
Rx
inh
R03AL02
ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE EQ 0.083% BASE;0.0 sol
N
inh
R03AL02
ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE EQ 0.083% BASE;0.0 sol
Y
Rx
inh
R03AL02
ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE EQ 0.083% BASE;0.0 sol
N
inh
R03AL02
ALBUTEROL SULFATE; IPRATROPIUM BROMIDE 0.5MG; 0.017% sol
Y
Rx
inh
R03AL02
COMBIVENT EQ 0.09MG BASE/INH;0.018MG/INH md aerosol
N
inh
R03AL02
COMBIVENT RESPIMAT EQ 0.1MG BASE/INH;0.02MG/INH md spray
Y
Rx
inh
R03AL02
DUONEB sol
N
inh
R03AL02
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE EQ 0.083% BASE;0.0 sol
77117/1
ANDA
31-12-2007
ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE EQ 0.083% BASE;0.0 sol
206532/1
ANDA
08-07-2020
ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE EQ 0.083% BASE;0.0 sol
77559/1
ANDA
31-12-2007
ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE EQ 0.083% BASE;0.0 sol
76867/1
ANDA
21-12-2006
ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE EQ 0.083% BASE;0.0 sol
76749/1
ANDA
31-12-2007
ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE EQ 0.083% BASE;0.0 sol
207875/1
ANDA
07-08-2017
ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE EQ 0.083% BASE;0.0 sol
76724/1
ANDA
31-12-2007
ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE EQ 0.083% BASE;0.0 sol
202496/1
ANDA
01-10-2012
ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE EQ 0.083% BASE;0.0 sol
77063/1
ANDA
31-12-2007
ALBUTEROL SULFATE; IPRATROPIUM BROMIDE 0.5MG; 0.017% sol
76749/2
ANDA
COMBIVENT EQ 0.09MG BASE/INH;0.018MG/INH md aerosol
20291/1
NDA
24-10-1996
COMBIVENT RESPIMAT EQ 0.1MG BASE/INH;0.02MG/INH md spray
21747/1
NDA
07-10-2011
DUONEB sol
20950/1
NDA
21-03-2001
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Europe

Austria (1)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
COMBIVENT FüR EINEN VERNEBLER IN EINZELDOSISBEHäLTNISSEN sol
Rx
-
R03AL02
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
COMBIVENT FüR EINEN VERNEBLER IN EINZELDOSISBEHäLTNISSEN sol
1-21541
11-07-1996
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Belgium (0)
No result.
Bosnia and Herzegovina (0)
No result.
Croatia (1)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
IPRATROPIJEV BROMID/SALBUTAMOL CIPLA 0,5 MG/2,5 MG U 2,5 ML, nebuliser sol
10 amp 2,5 ml otopina
100 amp 2,5 ml otopina
20 amp 2,5 ml otopina
40 amp 2,5 ml otopina
60 amp 2,5 ml otopina
80 amp 2,5 ml otopina
Y
Y
Y
Y
Y
Y
Rx
Rx
Rx
Rx
Rx
Rx
-
R03AL02
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
IPRATROPIJEV BROMID/SALBUTAMOL CIPLA 0,5 MG/2,5 MG U 2,5 ML, nebuliser sol
10 amp 2,5 ml otopina
100 amp 2,5 ml otopina
20 amp 2,5 ml otopina
40 amp 2,5 ml otopina
60 amp 2,5 ml otopina
80 amp 2,5 ml otopina
HR-H-807555647-01
HR-H-807555647-06
HR-H-807555647-02
HR-H-807555647-03
HR-H-807555647-04
HR-H-807555647-05
02-08-2019
02-08-2019
02-08-2019
02-08-2019
02-08-2019
02-08-2019
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Czechia (0)
No result.
Denmark (4)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
COMBIVENT 2,5+0,5 MG/BEHOLD. nebuliser sol
-
-
R03AL02
IPRAMOL STERI-NEB 2,5+0,5 MG/BEHOLD. nebuliser sol
-
-
R03AL02
IPRATROPIUM/SALBUTAMOL ORION 0,5+2,5 MG/BEHOLDER nebuliser sol
-
-
R03AL02
SAPIMOL 2,5+0,5 MG/BEHOLD. nebuliser sol
-
-
R03AL02
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
COMBIVENT 2,5+0,5 MG/BEHOLD. nebuliser sol
28101774595
NP
06-05-1996
IPRAMOL STERI-NEB 2,5+0,5 MG/BEHOLD. nebuliser sol
28104130807
MRP
12-12-2007
IPRATROPIUM/SALBUTAMOL ORION 0,5+2,5 MG/BEHOLDER nebuliser sol
28105297713
DCP
13-11-2014
SAPIMOL 2,5+0,5 MG/BEHOLD. nebuliser sol
28104167807
MRP
02-11-2007
Product
Pack
Ex-fact
Wholesale
Net retail
Gr. retail
Company
COMBIVENT 2,5+0,5 MG/BEHOLD. nebuliser sol
IPRAMOL STERI-NEB 2,5+0,5 MG/BEHOLD. nebuliser sol
IPRATROPIUM/SALBUTAMOL ORION 0,5+2,5 MG/BEHOLDER nebuliser sol
SAPIMOL 2,5+0,5 MG/BEHOLD. nebuliser sol
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Finland (2)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
ATRODUAL nebuliser sol
60 x 2.5 ml in single-dose container
Y
Rx
-
R03AL02
IPRATROPIUM/SALBUTAMOL ORION 0.5 MG / 2.5 MG PER 2.5 ML nebuliser sol
10 x 2.5 ml in ampoule
100 x 2.5 ml in ampoule
20 x 2.5 ml in ampoule
40 x 2.5 ml in ampoule
60 x 2.5 ml in ampoule
80 x 2.5 ml in ampoule
N
N
N
N
Y
N
Rx
Rx
Rx
Rx
Rx
Rx
-
R03AL02
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
ATRODUAL nebuliser sol
60 x 2.5 ml in single-dose container
12394
-
24-02-1997
IPRATROPIUM/SALBUTAMOL ORION 0.5 MG / 2.5 MG PER 2.5 ML nebuliser sol
10 x 2.5 ml in ampoule
100 x 2.5 ml in ampoule
20 x 2.5 ml in ampoule
40 x 2.5 ml in ampoule
60 x 2.5 ml in ampoule
80 x 2.5 ml in ampoule
31749
31749
31749
31749
31749
31749
-
-
-
-
-
-
16-04-2015
16-04-2015
16-04-2015
16-04-2015
16-04-2015
16-04-2015
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Hungary (0)
No result.
Iceland (0)
No result.
Ireland (2)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
COMBIPRASAL 0.5 MG/2.5 MG PER 2.5 ML nebuliser sol
Y
Rx
inh
R03AL02
IPRAMOL STERI-NEB 0.5MG/2.5MG PER 2.5ML 0.5/2.5 MG/MG nebuliser sol
Y
Rx
inh
R03AL02
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
COMBIPRASAL 0.5 MG/2.5 MG PER 2.5 ML nebuliser sol
PA1815/001/001
10-01-2014
IPRAMOL STERI-NEB 0.5MG/2.5MG PER 2.5ML 0.5/2.5 MG/MG nebuliser sol
PA1986/082/001
15-04-2005
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Lithuania (0)
No result.
Malta (0)
No result.
Netherlands (7)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
COMBIVENT UNIT DOSE nebuliser sol
-
Rx
inh
R03AL02
IPRAMOL STERI-NEB 0,5 MG / 2,5 MG PER 2,5 ML nebuliser sol
-
Rx
inh
R03AL02
IPRASA 0,5 MG / 2,5 MG PER 2,5 ML nebuliser sol
-
Rx
inh
R03AL02
IPRATROPIUMBROMIDE/SALBUTAMOL CIPLA 0,5/2,5 MG PER 2,5 ML nebuliser sol
-
Rx
inh
R03AL02
IPRATROPIUMBROMIDE/SALBUTAMOL SANDOZ 0,5 MG/2,5 MG PER 2,5 M nebuliser sol
-
Rx
inh
R03AL02
IPRATROPIUMBROMIDE/SALBUTAMOL SANDOZ 0,5/2,5 MG PER 2,5 ML nebuliser sol
-
Rx
inh
R03AL02
ZERSEOS 0,5 MG/2,5 MG PER 2,5 ML nebuliser sol
-
Rx
inh
R03AL02
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
COMBIVENT UNIT DOSE nebuliser sol
RVG 20233
-
03-11-1997
IPRAMOL STERI-NEB 0,5 MG / 2,5 MG PER 2,5 ML nebuliser sol
RVG 33224
-
26-09-2006
IPRASA 0,5 MG / 2,5 MG PER 2,5 ML nebuliser sol
RVG 112344
-
06-12-2013
IPRATROPIUMBROMIDE/SALBUTAMOL CIPLA 0,5/2,5 MG PER 2,5 ML nebuliser sol
RVG 114132
-
03-12-2014
IPRATROPIUMBROMIDE/SALBUTAMOL SANDOZ 0,5 MG/2,5 MG PER 2,5 M nebuliser sol
RVG 100362
-
30-07-2008
IPRATROPIUMBROMIDE/SALBUTAMOL SANDOZ 0,5/2,5 MG PER 2,5 ML nebuliser sol
RVG 109136
-
17-10-2012
ZERSEOS 0,5 MG/2,5 MG PER 2,5 ML nebuliser sol
RVG 118115
-
22-02-2017
Product
Pack
SPC
PIL
Company
COMBIVENT UNIT DOSE nebuliser sol
IPRAMOL STERI-NEB 0,5 MG / 2,5 MG PER 2,5 ML nebuliser sol
IPRASA 0,5 MG / 2,5 MG PER 2,5 ML nebuliser sol
IPRATROPIUMBROMIDE/SALBUTAMOL CIPLA 0,5/2,5 MG PER 2,5 ML nebuliser sol
IPRATROPIUMBROMIDE/SALBUTAMOL SANDOZ 0,5 MG/2,5 MG PER 2,5 M nebuliser sol
IPRATROPIUMBROMIDE/SALBUTAMOL SANDOZ 0,5/2,5 MG PER 2,5 ML nebuliser sol
ZERSEOS 0,5 MG/2,5 MG PER 2,5 ML nebuliser sol
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Norway (1)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
COMBIVENT UDV INH VæSKE TIL NEBULISATOR Inhalasjonsvæske til nebulisator, oppløsning
60 x 2.5
-
Rx
inh
R03AL02
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
COMBIVENT UDV INH VæSKE TIL NEBULISATOR Inhalasjonsvæske til nebulisator, oppløsning
60 x 2.5
01-01-2001
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Poland (1)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
IPRIXON NEB (0,5 MG + 2,5 MG)/2,5 ML nebuliser sol
20 amp 2,5 ml
30 amp 2,5 ml
-
-
Rx
Rx
-
R03AL02
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
IPRIXON NEB (0,5 MG + 2,5 MG)/2,5 ML nebuliser sol
20 amp 2,5 ml
30 amp 2,5 ml
24237
24237
DCP
DCP
31-08-2022
31-08-2022
Product
Pack
SPC
PIL
Company
IPRIXON NEB (0,5 MG + 2,5 MG)/2,5 ML nebuliser sol
20 amp 2,5 ml
30 amp 2,5 ml
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Romania (1)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
IPRATROPIU/SALBUTAMOL AMRING 0,5 MG/2,5 MG SOL. DE INHALAT PRIN NEBULIZATOR
12 pungi triplu laminate PE-Al-PET x 5 f
16 pungi triplu laminate PE-Al-PET x 5 f
2 pungi triplu laminate PE-Al-PET x 5 fi
20 pungi triplu laminate PE-Al-PET x 5 f
4 pungi triplu laminate PE-Al-PET x 5 fi
8 pungi triplu laminate PE-Al-PET x 5 fi
-
-
-
-
-
-
P6L
P6L
P6L
P6L
P6L
P6L
-
R03AL02
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
IPRATROPIU/SALBUTAMOL AMRING 0,5 MG/2,5 MG SOL. DE INHALAT PRIN NEBULIZATOR
12 pungi triplu laminate PE-Al-PET x 5 f
16 pungi triplu laminate PE-Al-PET x 5 f
2 pungi triplu laminate PE-Al-PET x 5 fi
20 pungi triplu laminate PE-Al-PET x 5 f
4 pungi triplu laminate PE-Al-PET x 5 fi
8 pungi triplu laminate PE-Al-PET x 5 fi
-
-
-
-
-
-
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Slovenia (1)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
IPRATROPIJEV BROMID/SALBUTAMOL CIPLA 0,5 MG/2,5 MG V 2,5 ML nebuliser sol
60 amp iz polietilena 2,5 ml sol (12 x 5
-
Rx
inh
R03AL02
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
IPRATROPIJEV BROMID/SALBUTAMOL CIPLA 0,5 MG/2,5 MG V 2,5 ML nebuliser sol
60 amp iz polietilena 2,5 ml sol (12 x 5
103-147/2016-4
DCP
24-01-2017
24-01-2017
24-01-2017
Product
Pack
Ex-fact
Wholesale
Net retail
Gr. retail
Company
IPRATROPIJEV BROMID/SALBUTAMOL CIPLA 0,5 MG/2,5 MG V 2,5 ML nebuliser sol
60 amp iz polietilena 2,5 ml sol (12 x 5
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Spain (2)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
COMBIPRASAL 0.5 MG/2.5 MG nebuliser sol
20 amp of 2,5 ml
Y
Rx
inh
R03AL02
IPRATROPIO BROMURO/SALBUTAMOL CIPLA 0,5 MG/2,5 MG nebuliser sol
20 amp of 2,5 ml
Y
Rx
inh
R03AL02
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
COMBIPRASAL 0.5 MG/2.5 MG nebuliser sol
20 amp of 2,5 ml
73561
22-02-2011
IPRATROPIO BROMURO/SALBUTAMOL CIPLA 0,5 MG/2,5 MG nebuliser sol
20 amp of 2,5 ml
82145
13-06-2017
Product
Pack
SPC
PIL
Company
COMBIPRASAL 0.5 MG/2.5 MG nebuliser sol
20 amp of 2,5 ml
IPRATROPIO BROMURO/SALBUTAMOL CIPLA 0,5 MG/2,5 MG nebuliser sol
20 amp of 2,5 ml
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Sweden (8)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
COMBIVENT 0,5 MG/2,5 MG nebuliser sol
Rx
-
R03AL02
COMBIVENT 0,5 MG/2,5 MG nebuliser sol
Rx
Rx
-
R03AL02
COMBIVENT 0,5 MG/2,5 MG nebuliser sol
Rx
Rx
-
R03AL02
IPRAMOL 0,5 MG / 2,5 MG PER 2,5 ML nebuliser sol
Rx
-
R03AL02
IPRATROPIUM/SALBUTAMOL ORION (FD IPRATROPIUMBROMID/SALBUTAMO nebuliser sol
Rx
-
R03AL02
IPRATROPIUM/SALBUTAMOL SANDOZ 0,5 MG/2,5 MG nebuliser sol
Rx
-
R03AL02
SALIPRA 0,5 MG/2,5 MG nebuliser sol
Rx
-
R03AL02
SAPIMOL 0,5 MG/2,5 MG PER 2,5 ML nebuliser sol
Rx
-
R03AL02
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
COMBIVENT 0,5 MG/2,5 MG nebuliser sol
Nationell decentral eller ömsesidig
20-02-1998
COMBIVENT 0,5 MG/2,5 MG nebuliser sol
PI
PI
23-08-2012
23-08-2012
31-12-2013
31-12-2013
COMBIVENT 0,5 MG/2,5 MG nebuliser sol
PI
PI
23-06-2016
23-06-2016
31-01-2018
31-01-2019
IPRAMOL 0,5 MG / 2,5 MG PER 2,5 ML nebuliser sol
Nationell decentral eller ömsesidig
05-05-2006
IPRATROPIUM/SALBUTAMOL ORION (FD IPRATROPIUMBROMID/SALBUTAMO nebuliser sol
Nationell decentral eller ömsesidig
06-11-2014
IPRATROPIUM/SALBUTAMOL SANDOZ 0,5 MG/2,5 MG nebuliser sol
Nationell decentral eller ömsesidig
07-03-2013
SALIPRA 0,5 MG/2,5 MG nebuliser sol
Nationell decentral eller ömsesidig
26-02-2015
SAPIMOL 0,5 MG/2,5 MG PER 2,5 ML nebuliser sol
Nationell decentral eller ömsesidig
04-04-2008
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Switzerland (2)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
DOSPIR Inhalationslösung (Einzeldosen)
-
-
B
B
-
R03AL02
IPRAMOL STERI-NEBS Lösung für einen Vernebler
-
-
B
B
-
R03AL02
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
DOSPIR Inhalationslösung (Einzeldosen)
53844 1
53844 1
Hauptzulassung
Hauptzulassung
24-11-1997
24-11-1997
12-07-2022
12-07-2022
IPRAMOL STERI-NEBS Lösung für einen Vernebler
58253 1
58253 1
Hauptzulassung
Hauptzulassung
03-06-2008
03-06-2008
02-06-2023
02-06-2023
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.